{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:54:32Z","timestamp":1767113672985,"version":"3.48.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.medcli.2025.107048","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T05:13:17Z","timestamp":1749791597000},"page":"107048","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic significance of carcinoembryonic antigen and anti-MDA5 antibodies in polymyositis\/dermatomyositis-associated rapidly progressive interstitial lung disease"],"prefix":"10.1016","volume":"165","author":[{"given":"Pengfang","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wengting","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Binbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2025.107048_bib0150","doi-asserted-by":"crossref","first-page":"103335","DOI":"10.1016\/j.autrev.2023.103335","article-title":"The prevalence and effects of treatments of rapidly progressive interstitial lung disease of dermatomyositis\/polymyositis adults: a systematic review and meta-analysis","volume":"22","author":"Wang","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.medcli.2025.107048_bib0155","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s40257-020-00502-6","article-title":"Dermatomyositis: an update on diagnosis and treatment","volume":"21","author":"Cobos","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0160","doi-asserted-by":"crossref","first-page":"e24726","DOI":"10.1002\/jcla.24726","article-title":"Roles of biomarkers in anti-MDA5-positive dermatomyositis, associated interstitial lung disease, and rapidly progressive interstitial lung disease","volume":"36","author":"Li","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.medcli.2025.107048_bib0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","article-title":"Interstitial lung disease in anti-MDA5 positive dermatomyositis","volume":"60","author":"Wu","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.medcli.2025.107048_bib0170","doi-asserted-by":"crossref","first-page":"151959","DOI":"10.1016\/j.semarthrit.2022.151959","article-title":"Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: a systematic review","volume":"53","author":"McPherson","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.medcli.2025.107048_bib0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/BOR.0000000000000979","article-title":"New therapies in anti-MDA5 antibody-positive dermatomyositis","volume":"36","author":"Yasui","year":"2024","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0180","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/1346-8138.15274","article-title":"Combined immunosuppressive therapy provides favorable prognosis and increased risk of cytomegalovirus reactivation in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis","volume":"47","author":"Matsuda","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0185","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2025.107048_bib0190","doi-asserted-by":"crossref","first-page":"e003850","DOI":"10.1136\/rmdopen-2023-003850","article-title":"Pretreatment mortality risk prediction model in patients with polymyositis\/dermatomyositis-associated interstitial lung disease","volume":"10","author":"Gui","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.medcli.2025.107048_bib0195","doi-asserted-by":"crossref","first-page":"692","DOI":"10.3390\/medicina57070692","article-title":"High-resolution CT findings of myositis-related interstitial lung disease","volume":"57","author":"Egashira","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.medcli.2025.107048_bib0200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s003300000648","article-title":"High-resolution CT of diffuse interstitial lung disease: key findings in common disorders","volume":"11","author":"Schaefer-Prokop","year":"2001","journal-title":"Eur Radiol"},{"key":"10.1016\/j.medcli.2025.107048_bib0205","first-page":"450","article-title":"Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease","volume":"30","author":"Tada","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","article-title":"Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress","volume":"20","author":"Lu","year":"2024","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/14397595.2017.1318468","article-title":"Evaluation of clinical prognostic factors for interstitial pneumonia in anti-MDA5 antibody-positive dermatomyositis patients","volume":"28","author":"Fujiki","year":"2018","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0220","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1440-1843.2012.02231.x","article-title":"Serum carcinoembryonic antigen correlates with severity of idiopathic pulmonary fibrosis","volume":"17","author":"Fahim","year":"2012","journal-title":"Respirology"},{"key":"10.1016\/j.medcli.2025.107048_bib0225","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2169\/internalmedicine1962.24.236","article-title":"Carcinoembryonic antigen in bronchoalveolar lavage fluid in patients with idiopathic pulmonary fibrosis","volume":"24","author":"Takahashi","year":"1985","journal-title":"Jpn J Med"},{"key":"10.1016\/j.medcli.2025.107048_bib0230","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/rheumatology\/keaa819","article-title":"Elevated carcinoembryonic antigen predicts rapidly progressive interstitial lung disease in clinically amyopathic dermatomyositis","volume":"60","author":"Zhu","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2025.107048_bib0235","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/bs.pmbts.2018.12.011","article-title":"Serum CEA levels in 49 different types of cancer and noncancer diseases","volume":"162","author":"Hao","year":"2019","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.1016\/j.medcli.2025.107048_bib0240","first-page":"211","article-title":"Clinical features and prognosis of idiopathic inflammatory myopathies with coexistent multiple myositis-specific antibodies","volume":"43","author":"Liang","year":"2025","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0245","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/art.24621","article-title":"RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease","volume":"60","author":"Sato","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2025.107048_bib0250","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1080\/17843286.2017.1420521","article-title":"Anti-MDA5 positive dermatomyositis complicated with rapidly progressive interstitial lung disease \u2013 a case report","volume":"73","author":"De Backer","year":"2018","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.medcli.2025.107048_bib0255","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00296-018-3991-7","article-title":"Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review","volume":"38","author":"Gonz\u00e1lez-Moreno","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.medcli.2025.107048_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rmed.2018.05.010","article-title":"Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies","volume":"140","author":"Yamaguchi","year":"2018","journal-title":"Respir Med"},{"key":"10.1016\/j.medcli.2025.107048_bib0265","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1164\/rccm.202203-0474ED","article-title":"On target: CYFRA 21-1 as an idiopathic pulmonary fibrosis biomarker","volume":"205","author":"Spagnolo","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2025.107048_bib0270","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1164\/rccm.202107-1769OC","article-title":"CYFRA 21-1 predicts progression in idiopathic pulmonary fibrosis: a prospective longitudinal analysis of the PROFILE cohort","volume":"205","author":"Molyneaux","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.medcli.2025.107048_bib0275","doi-asserted-by":"crossref","DOI":"10.1177\/17534666241250332","article-title":"Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease","volume":"18","author":"Ba","year":"2024","journal-title":"Ther Adv Respir Dis"},{"key":"10.1016\/j.medcli.2025.107048_bib0280","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1093\/rheumatology\/keaa843","article-title":"Cytokeratin 19 fragment is associated with severity and poor prognosis of interstitial lung disease in anti-MDA5 antibody-positive dermatomyositis","volume":"60","author":"Gui","year":"2021","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.medcli.2025.107048_bib0285","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/art.41554","article-title":"Distinct expression of coinhibitory molecules on alveolar T cells in patients with rheumatoid arthritis-associated and idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"73","author":"Nakazawa","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.medcli.2025.107048_bib0290","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/rheumatology\/key341","article-title":"CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease","volume":"58","author":"Wang","year":"2019","journal-title":"Rheumatology (Oxford)"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325002763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775325002763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T16:51:48Z","timestamp":1767113508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775325002763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0025775325002763"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107048","relation":{},"ISSN":["0025-7753"],"issn-type":[{"type":"print","value":"0025-7753"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic significance of carcinoembryonic antigen and anti-MDA5 antibodies in polymyositis\/dermatomyositis-associated rapidly progressive interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2025.107048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107048"}}